UCLA Research Uses Saliva to Detect Cancer Biomarkers

UCLA Research Uses Saliva to Detect Cancer Biomarkers

The published research, “Proficiency Testing of Epidermal Growth Factor Receptor Mutations Detection in Saliva Using Spectrum Saliva Collector (SDNA-1000) and Preservative Solution Detected by Electric Field-Induced Release and Measurement,” Feng Li et al, is an unprecedented feat in modern medicine. The ability to detect EGFR mutations using ctDNA enables a broad range of clinical applications for laboratory medicine such as the early detection of disease, practical applications of personalized treatments, predicting treatment response and monitoring resistance,” said Rohit Gupta, Chief Medical Officer for Spectrum Solutions.

Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2022 Netspective Media LLC. All Rights Reserved.

Built on Sep 30, 2022 at 7:39am